MicroRNA-486-5p improves nonsmall-cell lung cancer chemotherapy sensitivity and inhibits epithelial–mesenchymal transition by targeting twinfilin actin binding protein 1
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-486-5p improves nonsmall-cell lung cancer chemotherapy sensitivity and inhibits epithelial–mesenchymal transition by targeting twinfilin actin binding protein 1
Authors
Keywords
-
Journal
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Volume -, Issue -, Pages 030006051985073
Publisher
SAGE Publications
Online
2019-05-23
DOI
10.1177/0300060519850739
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis
- (2018) Yu-Hsuan Lai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Critical Micrornas in Lung Cancer: Recent Advances and Potential Applications
- (2018) Habib Zarredar et al. Anti-Cancer Agents in Medicinal Chemistry
- MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
- (2017) Irina Fadejeva et al. Oncotarget
- MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy
- (2017) Yichen Meng et al. Scientific Reports
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- (2016) D.A. Fennell et al. CANCER TREATMENT REVIEWS
- 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
- (2014) B. Besse et al. ANNALS OF ONCOLOGY
- miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124
- (2014) Yi Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Particle Therapy for Non-Small Cell Lung Tumors: Where Do We Stand? A Systematic Review of the Literature
- (2014) Krista C. J. Wink et al. Frontiers in Oncology
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
- (2013) Jessica Bockhorn et al. Nature Communications
- Actin-depolymerizing factor homology domain: A conserved fold performing diverse roles in cytoskeletal dynamics
- (2011) Minna Poukkula et al. Cytoskeleton
- More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer
- (2010) Tracy Putoczki et al. JOURNAL OF LEUKOCYTE BIOLOGY
- MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme
- (2009) Yiming Li et al. BRAIN RESEARCH
- Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin
- (2009) Guo-Qing Chen et al. MEDICAL ONCOLOGY
- In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression
- (2009) Corbin E Meacham et al. NATURE GENETICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started